bioAffinity Technologies Has Received A Notice Of Allowance For A U.S. Patent Titled "DETECTION OF EARLY-STAGE LUNG CANCER IN SPUTUM USING AUTOMATED FLOW CYTOMETRY AND MACHINE LEARNING".